Quantification of muscle pathology in infantile Pompe disease

被引:19
|
作者
Schaenzer, Anne [1 ]
Kaiser, Ann-Kathrin [1 ]
Muehlfeld, Christian [2 ]
Kulessa, Martin [1 ]
Paulus, Werner [3 ]
von Pein, Harald [4 ]
Rohrbach, Marianne [5 ]
Viergutz, Lara [1 ]
Mengel, Eugen [6 ]
Marquardt, Thorsten [7 ]
Neubauer, Bernd [8 ]
Acker, Till [1 ]
Hahn, Andreas [8 ]
机构
[1] Justus Liebig Univ, Inst Neuropathol, Giessen, Germany
[2] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany
[3] Univ Med Ctr, Inst Neuropathol, Munster, Germany
[4] Univ Med Ctr JGU Univ, Dept Neuropathol, Mainz, Germany
[5] Univ Childrens Hosp, Childrens Res Ctr, Div Metab, Zurich, Switzerland
[6] Univ Med Ctr JGU Univ, Villa Metab, Mainz, Germany
[7] Westfal Wilhelms Univ, Dept Pediat, Munster, Germany
[8] Justus Liebig Univ, Dept Child Neurol, Giessen, Germany
关键词
Pompe disease; Glycogen storage disease type II; Enzyme replacement therapy; Lysosomal storage disease; Acid maltase deficiency; Autophagy; ENZYME REPLACEMENT THERAPY; ACID ALPHA-GLUCOSIDASE; CLASSIC INFANTILE; CRIM STATUS; AUTOPHAGY;
D O I
10.1016/j.nmd.2016.10.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of enzyme replacement therapy (ERT) in infantile Pompe disease are variable, necessitating the identification of biomarkers to assess the severity of disease and response to ERT. The aims of this study were to investigate whether quantification of muscle pathology in infantile Pompe disease prior to and during ERT is feasible at the light microscope, and to develop a score that summarizes the degree of muscle pathology in a comprehensive manner from PAS-stained resin sections alone. We, therefore, determined glycogen load, extent of muscle fibre disruption, and amount of autophagic vacuoles in resin-embedded muscle biopsy specimens from 11 infantile Pompe patients and 2 with early childhood phenotype by quantitative methods, correlated the findings with ultrastructural analyses, compared PAS-stained resin sections with conventional PAS-stained cryosections, and related the quantified degree of muscle damage from infantile patients to the effects of ERT. Comparison of electron and light microscopic findings demonstrated that important alterations of skeletal muscle morphology can also be depicted by examining PAS stained resin sections. Infantile patients with good response to ERT had lower muscle pathology score values prior to and during ERT than those with moderate and poor response, but the number of tissue samples available for evaluation was limited. These findings suggest that quantification of muscle pathology by analysing PAS stained resin sections is in principle feasible and useful to monitor disease progression and therapy response. These results have to be validated by investigating a larger group of patients. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 50 条
  • [41] A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells
    Takeshi Yoshida
    Tomonari Awaya
    Tatsuya Jonouchi
    Ryo Kimura
    Shigemi Kimura
    Takumi Era
    Toshio Heike
    Hidetoshi Sakurai
    Scientific Reports, 7
  • [42] Ketone metabolic therapy to improve muscle function and coordination in a mouse model of infantile onset Pompe disease
    D'Agostino, Dominic P.
    Poff, Angela
    Deblasi, Janine M.
    Moss, Sara E.
    Thomas, Natalya
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02) : 24 - 25
  • [43] Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy
    Winkel, LPF
    Kamphoven, JHJ
    Van Den Hout, HJMP
    Severijnen, LA
    Van Doorn, PA
    Reuser, AJJ
    Van Der Ploeg, AT
    MUSCLE & NERVE, 2003, 27 (06) : 743 - 751
  • [44] A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells
    Yoshida, Takeshi
    Awaya, Tomonari
    Jonouchi, Tatsuya
    Kimura, Ryo
    Kimura, Shigemi
    Era, Takumi
    Heike, Toshio
    Sakurai, Hidetoshi
    SCIENTIFIC REPORTS, 2017, 7
  • [45] HISTOLOGICAL ASSESSMENT OF SKELETAL MUSCLE IN PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY FOR INFANTILE ONSET POMPE DISEASE
    Kwok, A. M. K.
    Kan, A.
    Poon, G. W. K.
    Cheung, P. T.
    Low, L. C. K.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S196 - S196
  • [46] Post-Symptomatic Reversal of Muscle Pathology in a Model of Pompe Disease Using Gene Therapy
    Ramezani, Ali
    Hordeaux, Juliette
    Tuske, Steven
    Song, Chunjuan
    Mehta, Nickita
    Tsai, Patrick
    Weimer, Jill
    So, Meardey
    Bell, Peter
    Do, Hung
    Wilson, James M.
    MOLECULAR THERAPY, 2021, 29 (04) : 253 - 253
  • [47] Limitations of muscle biopsy in Pompe disease
    John Vissing
    BMC Musculoskeletal Disorders, 14 (Suppl 2)
  • [48] Respiratory muscle training in Pompe disease
    Jones, Harrison
    Crisp, Kelly
    Marcus, Jill
    Batten, Milisa
    Edds, Ashley
    Hobson-Webb, Lisa
    Kuchibhatla, Maragatha
    Kishnani, Priya
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S72 - S72
  • [49] Pompe disease: Smooth muscle involvement
    Hartung, R.
    Lehmann, V.
    Kampmann, C.
    Beck, M.
    Mengel, E.
    CLINICAL THERAPEUTICS, 2007, 29 : S119 - S120
  • [50] ULTRASTRUCTURAL MUSCLE PATHOLOGY IN INFANTILE NEUROAXONAL DYSTROPHY
    KIMURA, S
    SASAKI, Y
    BRAIN & DEVELOPMENT, 1988, 10 (05): : 327 - 329